MDAI Stock Summary and Trading Ideas (Spectral Ai - Class A | NASDAQ:MDAI)

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Spectral Ai - Class A trades on the NASDAQ stock market under the symbol MDAI.

As of December 19, 2025, MDAI stock price climbed to $1.55 with 283,102 million shares trading.

MDAI has a beta of 1.34, meaning it tends to be more sensitive to market movements. MDAI has a correlation of 0.06 to the broad based SPY ETF.

MDAI has a market cap of $47.57 million. This is considered a Sub-Micro Cap stock.

Last quarter Spectral Ai - Class A reported $4 million in Revenue and -$.13 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.05.

The top ETF exchange traded funds that MDAI belongs to (by Net Assets): VTI, VXF, IWC.

MDAI has underperformed the market in the last year with a price return of -17.6% while the SPY ETF gained +18.1%. MDAI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.7% and -6.1%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

MDAI support price is $1.40 and resistance is $1.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDAI shares will trade within this expected range on the day.